---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-105381"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T06:47:26.441502+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Onconova receives Nasdaq bid price deficiency notice; 180-day cure period to March 2024

## Summary
- Received Nasdaq notice on Sep 25, 2023 for failure to maintain $1.00 minimum bid price.
- Has until March 25, 2024 to regain compliance with closing bid >=$1 for 10 consecutive days.
- If not cured, may qualify for second 180-day period by meeting other standards and notifying intent to reverse split.
- Company says it will monitor options but cannot assure compliance.

## SEC filing metadata
- accession: 0001104659-23-105381
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465923105381/0001104659-23-105381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465923105381/tm2327211d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-105381
- JSON: https://secwatch.observer/filing/0001104659-23-105381.json
- Plain text: https://secwatch.observer/filing/0001104659-23-105381.txt

## Key facts
- Listing & Compliance Notices
  Traws Pharma, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: September 25, 2023, the Company received a letter from The Nasdaq Capital Market (“Nasdaq”) indicating that the Company has failed to comply with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Nasdaq Listing Rule 5550(a) (2) requires that companies listed on Nasdaq maintain a minimum closing bid price of at least $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a 180 calendar day grace period, or until March 25, 2024, to regain compliance by meeting the continued listing standard. The continued listing standard will be met if the Company’s common
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130598/000110465923105381/0001104659-23-105381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.